Lupin bags USFDA nod for Eslicarbazepine Acetate Tablets for partial-onset seizures
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600 mg, and 800 mg, to market a generic equivalent of Aptiom Tablets, 200 mg, 400 mg, […]